Evidence map›Paper›PMID 40028285›Full record

ArticleiScience2025

Inspired by struggle: A personal journey to global precision brain health.

Agustin Ibanez

Abstract readNews
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Linking the exposome to the brain-behaviour phenotype.Nature reviews. Neuroscience · 2026
    Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Agustin IbanezFull Professor and Scientific Director of the Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dr. Agustin Ibanez joins iScience editor Maryam Fard to discuss his personal journey in brain health research. He advocates for integrating diversity in neurodegeneration studies, crucial for understanding conditions like dementia. He founded ReDLat and BrainLat, advancing research across Latin America and empowering underrepresented voices. This inspiring discussion showcases his commitment to fostering interdisciplinary approaches to drive global brain health progress. Dr. Ibanez is also the Guest Editor of iScience's Special Issue: "Transdisciplinary approaches to arts and health: Integrating creative practice in clinical and public health contexts."

Identifiers

PMID40028285
PMCPMC11869526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.